Utama › Glioblastoma
Kajian klinikal Glioblastoma sedang mengambil peserta di AS
157 kajian untuk Glioblastoma sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY30 kajian
- Boston, MA28 kajian
- Houston, TX25 kajian
- Los Angeles, CA23 kajian
- Durham, NC20 kajian
- San Francisco, CA17 kajian
- Washington, DC15 kajian
- Rochester, MN15 kajian
- Chicago, IL15 kajian
- Miami, FL14 kajian
- Columbus, OH14 kajian
- Jacksonville, FL13 kajian
- Aurora, CO12 kajian
- St. Louis, MO12 kajian
- Atlanta, GA11 kajian
- Salt Lake City, UT11 kajian
- Philadelphia, PA11 kajian
- Baltimore, MD11 kajian
- Cleveland, OH11 kajian
- Baldwin Park, CA10 kajian
- Pittsburgh, PA9 kajian
- Birmingham, AL9 kajian
- Dallas, TX9 kajian
- Nashville, TN9 kajian
- Phoenix, AZ8 kajian
- Winston-Salem, NC8 kajian
- Seattle, WA8 kajian
- San Antonio, TX8 kajian
- San Diego, CA7 kajian
- Edison, NJ7 kajian
- Cincinnati, OH6 kajian
- Tampa, FL6 kajian
- Madison, WI6 kajian
- Ann Arbor, MI6 kajian
- Lexington, KY5 kajian
- Mountain View, CA5 kajian
- Queens, NY5 kajian
- Omaha, NE5 kajian
- Arlington, VA5 kajian
- Charlottesville, VA5 kajian
Mengikut negeri
- Alabama9 kajian
- Arizona13 kajian
- California40 kajian
- Colorado14 kajian
- Connecticut5 kajian
- Florida30 kajian
- Georgia12 kajian
- Illinois16 kajian
- Indiana4 kajian
- Iowa4 kajian
- Kansas3 kajian
- Kentucky5 kajian
- Maryland16 kajian
- Massachusetts29 kajian
- Michigan11 kajian
- Minnesota19 kajian
- Missouri12 kajian
- Nebraska5 kajian
- New Jersey8 kajian
- New York33 kajian
- North Carolina26 kajian
- Ohio23 kajian
- Oklahoma4 kajian
- Pennsylvania21 kajian
- Rhode Island3 kajian
- South Carolina3 kajian
- Tennessee10 kajian
- Texas33 kajian
- Utah11 kajian
- Virginia10 kajian
- Washington9 kajian
- Wilayah Columbia9 kajian
- Wisconsin8 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06991101Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05432804A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT03970447GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07301268GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Mengambil pesertaFasa 1
Umur 21 hingga 70 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06815432The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07285044Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05902169Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07326566A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05303467Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Mengambil pesertaFasa 1/2
Umur 18 hingga 99 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07416188Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07145112A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Mengambil pesertaFasa 1/2
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT04094610Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07195591MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT03896568Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06047379RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
Mengambil pesertaFasa 1
Umur 18 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06389591OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
Mengambil pesertaFasa 2
Umur 18 hingga 90 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06558214Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Mengambil pesertaFasa 1/2
Umur 18 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06814496A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT05765812Anti-GD2 ADC M3554 in Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06641908VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
Mengambil pesertaFasa 2
Umur 18 hingga 98 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07831369REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07831772Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT04977375ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07089641A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Mengambil pesertaFasa 1
Umur 19 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05698524Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.